International AIDS Society Conference Starts Sunday

The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) will kick of Sunday, June 30, in Kuala Lumpur Malaysia. Key areas of interest will include new developments in antiretroviral therapy, biomedical HIV prevention, and improving access to and retention in care.alt

UNAIDS: HIV Infections among Children Drop by Half in African Countries

New HIV infections among children by fallen by at least 50% since 2009 in 7 high-prevalence countries in sub-Saharan Africa, largely due to improvements in preventing mother-to-child transmission, according to a Global Plan progress report issued this week by UNAIDS.


People with Well-Controlled HIV Can Match Lifespan of HIV Negatives

People with HIV who are able to achieve good viral suppression and CD4 cell recovery on antiretroviral therapy (ART) have a mortality rate similar to that of uninfected people in the general population, according to results from the large SMART and ESPRIT studies, published in the March 27, 2013 issue of AIDS.alt

Supreme Court Rules Against Anti-Prostitution Pledge for HIV/AIDS Funding

The Supreme Court of the U.S. this week struck down a provision that requires agencies receiving global HIV/AIDS funding to affirm their opposition to prostitution, stating that it is an unconstitutional restriction of free speech.


Senate Approves Bill to Allow HIV+ Patients to Receive HIV+ Donor Organs

The U.S. Senate this week unanimously passed the HOPE Act, a bill that will make an exception to current law enabling people with HIV to receive organs for transplantation from another HIV positive individual. The measure now awaits approval from the House of Representatives.


UNAIDS, Advocates Publish HIV Criminalization Reports; Webinar June 25

UNAIDS last month released a report on ending overly broad criminalization of HIV exposure and non-intentional transmission, emphasizing that laws should reflect the latest science. International advocates released their own report on HIV criminalization in early June, and the HIV Prevention Justice Alliance (HIVPJA) will hold a webinar on Tuesday, June 25, to strategize about the REPEAL HIV Criminalization Act.


New NRTI BMS-986001 Potently Suppresses HIV in Early Monotherapy Study

BMS-986001, a novel thymidine nucleoside reverse transcriptase inhibitor (NRTI) being developed by Bristol-Myers Squibb, demonstrated good antiviral activity and appeared safe and well-tolerated in a 10-day monotherapy study, researchers reported in the July 1, 2013, Journal of Acquired Immune Deficiency Syndromes.